Apr 8, 2022

Advocacy group’s advisory board members defect over Biogen Alzheimer’s drug

Posted by in categories: biotech/medical, life extension, neuroscience

The furious debate over Aduhelm has now sparked controversy over the Alliance for Aging Research, which has seen half of its scientific advisory board members resign.

Leave a reply